Rayner Newsroom

Find out more about the latest news taking place at Rayner!

Rayner Set to Launch 600C Monofocal Aspheric IOL in America at ASCRS

Read More»

Rayner has announced the US launch of the 600C Aspheric IOL. The 600C Aspheric IOL will be unveiled at the upcoming 2018 ASCRS conference in Washington, DC, 13-17 April, and product availability will begin following the conference. 

Built on the clinically-proven Rayner Primary IOL Platform, the 600C Aspheric is a hydrophilic acrylic aspheric monofocal IOL with Rayner’s Amon-Apple 360° Enhanced Square Edge. Soon to be available in the USA, Rayner’s global 6.0 mm lens design offers surgeons a sub-2.2 mm incision IOL for minimal wound damage and surgically-induced astigmatism (SIA), whilst retaining the optical performance of its predecessor, the Rayner C-flex.

RayOne Fully Preloaded IOL Injection System Now Available in Argentina

Read More»

Rayner, together with Iskowitz – Rayner’s exclusive distributor in Argentina -- announced today that the RayOne fully preloaded IOL injection system has received approval from the Argentine regulator, ‘Administración Nacional de Medicamentos, Alimentos y Tecnología Médica’ (ANMAT), and is now available for commercial use.

Product Approval Details

10-Year Milestones Achieved for Key Primary & Supplementary IOLs. 2017 in Review

Read More»

18 January, 2018. Worthing, United Kingdom. Over the course of 2017, Rayner marked the 10-year anniversary for receiving CE approval for the following IOLs:

  • Sulcoflex Aspheric
  • C-flex Aspheric
  • Superflex Aspheric
  • M-flex T Multifocal Toric

Surgeons in India to Access RayOne Fully Preloaded IOL Injection System

Read More»

Rayner announced today that their new RayOne fully preloaded IOL injection system has received Central Drugs Standard Organisation (CDSCO) approval and is being launched in India.

Product Approval Details
The CDSCO granted regulatory approval and sale of the RayOne aberration-neutral Aspheric (RAO600C) and the RayOne Spheric (RAO100C) for the full power range:

New Product Demonstrations, Launches and Presentations at the 2017 ESCRS in Lisbon

Read More»

Rayner announced today it’s schedule of events and opportunities for surgeons during the upcoming ESCRS Congress, on the Rayner booth #P207 (Pavilion 2), which includes the launch of the RayOne Trifocal IOL and a preview of the RayOne Hydrophobic IOL.

Keeping it simple: The New Rayner Website Experience

Read More»

For those of you who have visited the Rayner website over the last few days, you will have noticed we’re now offering a very different online experience; one that we believe is clearer and more user-friendly.

It’s all about navigation
Here are some of the changes we’ve made:

New Patented Trifocal Technology. Rayner Set to Launch RayOne® Trifocal at the Upcoming ESCRS

Read More»

14 September, 2017. Rayner are proud to announce the launch of the newest member of the RayOne® family of preloaded IOLs: the RayOne® Trifocal, to be unveiled at the upcoming 2017 ESCRS conference in Lisbon.

Product availability will be from 9 October 2017 to all CE registered markets.

Rayner Strengthens Commitment to US Market With Subsidiary Rayner Surgical Inc.

Read More»

With a large part of 2016 and 2017 focused on European expansion, Rayner announced today its investment into the US market with the establishment of a dedicated subsidiary, ‘Rayner Surgical Inc.’
Based out of New York, Rayner Surgical Inc. will provide US specific marketing, regulatory, commercial and research functions to Rayner.
Rayner’s latest lens platform – the 600C – has just received FDA approval and will be launched in the USA during 2018 in both manual and preloaded formats.

RayOne Fully Preloaded IOL Injection System Now Available in Brazil

Read More»

Rayner announced today the latest update in the RayOne story: registration of the RayOne Aspheric and Spheric monofocal fully preloaded IOL injection systems has been listed in the Federal Register by ANVISA, the Brazilian National Sanitary Surveillance Agency.

Product Approval Details
ANVISA granted regulatory approval and sale of the RayOne aberration-neutral Aspheric (RAO600C) and RayOne Spheric (RAO100C) for the full power range: 

New RayOne System Found Best Performing in 3 of 4 Areas Covered in Ex-Vivo Study

Read More»

An experimental study was recently conducted to compare current fully preloaded intraocular lens (IOL) injection systems on the market. 

The study explored wound architecture after IOL implantation and the overall ease and speed of use of the different IOL systems.

The new RayOne system was found to be best performing in 3 of the 4 areas covered within the study.